首页|期刊导航|中华医学杂志（英文版）|Pharmacokinetics and bioequivalence evaluation of lenalidomide in Chinese patients with multiple myeloma

Pharmacokinetics and bioequivalence evaluation of lenalidomide in Chinese patients with multiple myeloma

Tiantao Gao Xinghong Liu Qi Shen Zhu Luo Ping Feng Jia Miao Li Zheng Donglin Chen Jin Xiang

中华医学杂志（英文版）2022，Vol.135Issue(2)：250-252,3.

中华医学杂志（英文版）2022，Vol.135Issue(2)：250-252,3.DOI:10.1097/CM9.0000000000001695

Pharmacokinetics and bioequivalence evaluation of lenalidomide in Chinese patients with multiple myeloma

Tiantao Gao ¹Xinghong Liu ²Qi Shen ¹Zhu Luo ¹Ping Feng ¹Jia Miao ¹Li Zheng ¹Donglin Chen ²Jin Xiang¹

作者信息

1. Clinical Trial Center,West China Hospital of Sichuan University,Chengdu,Sichuan 610041,China
2. Department of Medicinal Natural Products,West China School of Pharmacy,Sichuan University,Chengdu,Sichuan 610041,China
折叠

摘要

引用本文复制引用

Tiantao Gao,Xinghong Liu,Qi Shen,Zhu Luo,Ping Feng,Jia Miao,Li Zheng,Donglin Chen,Jin Xiang..Pharmacokinetics and bioequivalence evaluation of lenalidomide in Chinese patients with multiple myeloma[J].中华医学杂志（英文版）,2022,135(2):250-252,3.

基金项目

The research was supported by the National Science and Technology Major Project of China (No.2017ZX09304023) and the Major Specific Project of Sichuan Province (No.2020YFS0034). （No.2017ZX09304023）

中华医学杂志（英文版）

OACSCDCSTPCDMEDLINESCI

ISSN：0366-6999

访问量0

下载量0

段落导航